Migraine and cluster headache treatment with calcium antagonists supports a vascular pathogenesis.
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009543:Nifedipine / Q000627:therapeutic use*; D009553:Nimodipine; D014653:Vascular Headaches / Q000188:drug therapy* / Q000503:physiopathology; D014700:Verapamil / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D009539:Nicotinic Acids; D009553:Nimodipine; D014700:Verapamil; D009543:Nifedipine